Notable 52-Week Highs and Lows 9/14: (EXEL) (LVS) (WYNN) High; (RNN) (RLGT) Low

September 14, 2016 3:16 PM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

52-Week High:
  • Exelixis, Inc. (Nasdaq: EXEL) $13.19. Exelixis announced that the European Commission (EC) has approved CABOMETYX (cabozantinib) tablets for the treatment of advanced renal cell carcinoma (RCC) in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy. CABOMETYX was granted accelerated assessment by the European Medicines Agency, and is the first therapy to demonstrate in a phase 3 trial for patients with advanced RCC, robust and clinically meaningful improvements in all three key efficacy parameters — overall survival (OS), progression-free survival (PFS) and objective response rate (ORR).

  • Las Vegas Sands (NYSE: LVS) $58.35. Argus upgraded Las Vegas Sands from Hold to Buy with a price target of $67.

  • Wynn Resorts (Nasdaq: WYNN) $107.67. Wynn Resorts gaining in concert with Las Vegas Sands today.
52-Week Low:
  • Rexahn Pharma (NYSE: RNN) $0.22. Rexahn Pharma announced it has entered into a definitive agreement with institutional investors to purchase 24 million shares of its common stock and warrants exercisable for up to 18 million shares of its common stock for gross proceeds of $6 million. The shares and warrants are being sold in units, each consisting of one share of common stock and a warrant to purchase 0.75 of a share of common stock, at an offering price of $0.25 per unit.

  • Radiant Logistics (NYSE: RLGT) $2.45. Radiant Logistics reported Q4 EPS of ($0.01), versus the analyst estimate of $0.03. Revenue for the quarter came in at $183.6 million versus the consensus estimate of $202.59 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities


Add Your Comment